Hollywood Stars Conquer Allergy-Inducing "Pollen Vortex" in Newly Released AirWare Labs Video
May 29 2014 - 8:10AM
Marketwired
Hollywood Stars Conquer Allergy-Inducing "Pollen Vortex" in Newly
Released AirWare Labs Video
"Mad Men" Star Vincent Kartheiser and Adam Herschman of
"Accepted" Demonstrate the Power of Allergy-Free Breathing With
AIR(R) Nasal Filters
SCOTTSDALE, AZ--(Marketwired - May 29, 2014) - With this year's
allergy season in full swing, AirWare Labs Corp. (OTCQB: AIRW) has
released a video starring TV and movie personalities Vincent
Kartheiser and Adam Herschman that demonstrates the effectiveness
of AIR® nasal filters against airborne allergens. Kartheiser
currently plays "Pete Campbell" on AMC's drama Mad Men,
and Herschman is best known for his roles in hit comedies
Accepted and Soul Men.
The video, titled Bubble Boy: AirWare Spokesperson
Auditions, features Kartheiser's character in a humorous
search for AirWare's new spokesperson. "Bubble Boy," played by
Herschman, wins the job after telling the story of his life spent
in a protective bubble -- until his discovery of AIR® filters
allowed him to escape from the bubble and live, and breathe,
freely.
"This project has been thrilling from start to finish," said
Jeffrey Rassás, CEO of AirWare Labs. "Working with Vincent and Adam
was incredible, and the video demonstrates their ability to capture
and hold an audience with just the right mix of energy and humor.
'Bubble Boy' is the ultimate spokesperson for AirWare, and we are
confident his story will reach millions of allergy sufferers
struggling through this prolific allergy season."
Designed with an integrated filter media from 3M, AIR filtered
inserts protect wearers from up to 99% of plant spores, airborne
pollens and viruses. AIR filters provide an effective solution to
this year's severe allergy season -- one the media attributes to a
"Pollen Vortex," the result of a long, cold winter and subsequent
blooming of pollen-producing trees all at one time. In fact, WebMD
predicts this will be the worst allergy season in the last four
years.
"With what we're hearing from our customers and in the news
about the severity of allergies right now, our video release
couldn't be more timely," said Rassás.
To help maximize online distribution, AirWare has partnered with
a well-known social video and seeding company. "By combining our
social media, marketing and PR campaign with our partner's network
of publishers and social platforms, we are able to greatly amplify
the reach of our video," said Chase Herschman, Director of
Marketing for AirWare Labs. "Timing is everything, and our
distribution plan is geared to reach the largest possible audience
right when people are seeking a solution like AIR."
About AirWare Labs Corporation:
AirWare Labs Corp. [publicly traded as (OTCQB: AIRW)] provides
patented and innovative technology solutions for consumer products
that promote better health through breathing and enhanced
wellbeing. AirWare Labs' products are marketed under the brand name
of AIR®. AIR® products utilize an FDA approved medical grade
material, molded as an intranasal Air Breathe dilator, to act as
the delivery system. This AIR® microstructure enhances normal nasal
airflow with every breath -- clinically proven to deliver up to 40%
more oxygen.
Some AIR® products are infused with essential oils with unique
healing properties including antibacterial and therapeutic defense
against airborne allergens, viruses and bacteria. AIR® Allergy and
Travel products provide additional defense in the form of an
integrated filter media from 3M to remove microscopic particles
that carry viruses, allergens and bacteria. Other AIR® specialty
products help provide and performance enhancements and relief from
congestion, insomnia, headaches, nausea, and snoring. For more
product information, please visit: http://www.airwarelabs.com or
company information visit: http://airwarelabscorp.com.
Forward-Looking Statement: The statements in this press release
regarding any implied or perceived benefits from the release by
AirWare Labs Corp. of its AIR® products are forward-looking
statements. Such statements involve risks and uncertainties,
including, but not limited to, risks and effects of legal and
administrative proceedings and governmental regulation, especially
in a foreign country, future financial and operational results,
competition, general economic conditions, and the ability to manage
and continue growth.
Should one or more of these risks or uncertainties materialize,
or should underlying assumptions prove incorrect, actual outcomes
may vary materially from those indicated. Important factors that
could cause actual results to differ materially from the
forward-looking statements we make in this news release include the
introduction of new technology, market conditions and those set
forth in reports or documents we file from time to time with the
SEC. We undertake no obligation to revise or update such statements
to reflect current events or circumstances after the date hereof or
to reflect the occurrence of unanticipated events.
Media Contact: Jennifer Breitegan jen@kwprgroup.com Investor
Relations: Keith Pinder Acorn Management 678-736-5682
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Jan 2025 to Feb 2025
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Feb 2024 to Feb 2025